- Home
- STI vs AEON Comparison
STI vs AEON Comparison
Compare STI & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STI
- AEON
- Stock Information
- Founded
- STI 2014
- AEON N/A
- Country
- STI United States
- AEON United States
- Employees
- STI N/A
- AEON N/A
- Industry
- STI
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- STI
- AEON Health Care
- Exchange
- STI NYSE
- AEON Nasdaq
- Market Cap
- STI 9.5M
- AEON 8.0M
- IPO Year
- STI N/A
- AEON N/A
- Fundamental
- Price
- STI $4.50
- AEON $0.79
- Analyst Decision
- STI
- AEON Strong Buy
- Analyst Count
- STI 0
- AEON 1
- Target Price
- STI N/A
- AEON $360.00
- AVG Volume (30 Days)
- STI 60.8K
- AEON 153.4K
- Earning Date
- STI 08-12-2025
- AEON 08-11-2025
- Dividend Yield
- STI N/A
- AEON N/A
- EPS Growth
- STI N/A
- AEON N/A
- EPS
- STI 6.72
- AEON 117.22
- Revenue
- STI N/A
- AEON N/A
- Revenue This Year
- STI N/A
- AEON N/A
- Revenue Next Year
- STI N/A
- AEON N/A
- P/E Ratio
- STI $0.67
- AEON $0.01
- Revenue Growth
- STI N/A
- AEON N/A
- 52 Week Low
- STI $2.94
- AEON $0.38
- 52 Week High
- STI $55.00
- AEON $215.31
- Technical
- Relative Strength Index (RSI)
- STI 51.66
- AEON 49.97
- Support Level
- STI $4.22
- AEON $0.80
- Resistance Level
- STI $5.59
- AEON $0.85
- Average True Range (ATR)
- STI 0.41
- AEON 0.05
- MACD
- STI 0.01
- AEON -0.01
- Stochastic Oscillator
- STI 24.78
- AEON 26.61
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a IP leader in both the high-capacity anode and the high-energy solid-state battery.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.